FUSION PROTEINS UTILIZING THE DECAY ACCELERATING FACTOR MEMBRANE BINDING DOMAIN

摘要

Novel fusions of a phospholipid anchor domain and apolypeptide heterologous to the anchor domain donor polypeptide areprovided for industrial use. Therapeutic administration of thefusions enables the targeting of biological activity to cellmembrane surfaces.